Puma Biotechnology Competitors and Similar CompaniesClear all
ImmunoGen's competitors and similar companies include Ascendis Pharma.
 ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  Ascendis Pharma Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology. | |
Founding Date | Founding Date 1981 | Founding Date 2007 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations Hellerup, DK HQ Heidelberg, DE Palo Alto, US |
Employees | Employees 277161% increase | Employees 1,017 |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 7.7 b |
Financial | ||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) €720.1m (FY, 2025) |
Cost of goods | Cost of goods $176k (FY, 2022) | Cost of goods €93.1m (FY, 2025) |
Gross profit | Gross profit $108.6m (FY, 2022) | Gross profit €627.1m (FY, 2025) |
Net income | Net income ($222.9m) (FY, 2022) | Net income (€228m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 85.8m |
For sources of this data, please see the company profile
View Company Profiles
Ascendis Pharma
HQ
Hellerup, DK
Employees
1,017
Ascendis Pharma is a biopharmaceutical company that specializes in endocrinology and oncology.
View company